2 Versus 6 Hour Oxaliplatin Infusions in Patients With Gastrointestinal Cancers
Status:
Recruiting
Trial end date:
2023-03-31
Target enrollment:
Participant gender:
Summary
This phase II trial studies how well giving oxaliplatin over 6 hours works in treating nerve
damage in patients with gastrointestinal cancers. Oxaliplatin can cause side effects such as
nerve damage that may delay or reduce the dose of oxaliplatin. Giving oxaliplatin over a
longer period of time (6 hours) may prevent or delay the development of nerve damage, which
may keep patients on standard doses of chemotherapy longer, without having to delay
treatment.
Phase:
Phase 2
Details
Lead Sponsor:
Emory University
Collaborators:
Hematology/Oncology Pharmacy Association University of Pittsburgh